|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: ENDO PHARMACEUTICALS HOLDINGS INC, 10-Q, EX-10.26, 2000-08-14 |
Next: ENDO PHARMACEUTICALS HOLDINGS INC, 10-Q, EX-27, 2000-08-14 |
<PAGE>
EXHIBIT 11
Endo Pharmaceuticals Holdings Inc.
Statement Regarding Computation of Per Share Earnings
<TABLE>
<CAPTION>
Three Months Ended Six Months Ended
June 30, June 30,
--------------------------------- ----------------------------------
2000 1999 2000 1999
--------------- -------------- --------------- ---------------
<S> <C> <C> <C> <C>
Numerator:
Net income (loss) available to
common stockholders $ 608 $ (2,638) $ (16,986) $ (3,717)
Denominator:
For basic per share data -
weighted average shares 71,328,424 71,333,979 71,326,680 71,335,335
Effect of dilutive stock options - - - -
For diluted per share data 71,328,424 71,333,979 71,326,680 71,335,335
Basic earnings (loss) per share $ .01 $ (.04) $ (.24) $ (.05)
Diluted earnings (loss) per share $ .01 $ (.04) $ (.24) $ (.05)
</TABLE>
|
|